造血体细胞嵌合与术后房颤风险增加相关
研究对104例接受主动脉瓣置换术患者用HemePACT panel(576基因)进行血液DNA基因分型,评估造血体细胞嵌合(HSM)与术后房颤(POAF)的关系。结果显示HSM患病率29%至60%,最宽泛定义下HSM携带者POAF风险高3.5倍(年龄校正OR 3.5;95%CI 1.52-8.03;P=0.003),并伴炎症反应增强。
要点
- HSM在主动脉瓣置换候选者中常见,患病率29%至60%取决于定义。
- HSM携带者术后房颤风险显著增高,年龄校正OR 3.5(95%CI 1.52-8.03)。
- HSM与术前心肌促炎单核细胞来源巨噬细胞富集及术后炎症反应增强相关。
核心结论
- HSM在主动脉瓣置换候选者中频繁存在,与促炎心脏单核细胞来源巨噬细胞富集相关,并易致术后房颤发生率升高。
研究设计与样本
- 研究纳入104例拟行外科主动脉瓣置换术患者,采用HemePACT panel(576基因)对血液DNA进行基因分型。
- 应用四种筛查方法评估HSM,并探索术后结局,部分患者接受质谱流式细胞术及经典单核细胞RNA测序分析。
主要发现
- HSM患病率从29%(传统HSM panel 97基因,变异等位基因频率≥2%)至60%(全HemePACT panel,变异等位基因频率≥1%)。
- 四种HSM定义中有三种与术后房颤风险增高显著相关。
- 基于最宽泛定义,HSM携带者术后房颤风险高3.5倍(年龄校正OR 3.5;95%CI 1.52-8.03;P=0.003)。
- HSM携带者术后炎症反应增强,术前外周血活化CD64+CD14+CD16-单核细胞及心肌炎症性单核细胞来源巨噬细胞水平更高。
临床怎么用
- HSM评估可能有助于围术期患者的个性化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: On-pump cardiac surgery triggers sterile inflammation and postoperative complications such as postoperative atrial fibrillation (POAF). Hematopoietic somatic mosaicism (HSM) is a recently identified risk factor for cardiovascular diseases and results in a shift toward a chronic proinflammatory monocyte transcriptome and phenotype. OBJECTIVES: The aim of this study was to assess the prevalence, characteristics, and impact of HSM on preoperative blood and myocardial myeloid cells as well as on outcomes after cardiac surgery. METHODS: Blood DNA from 104 patients referred for surgical aortic valve replacement (AVR) was genotyped using the HemePACT panel (576 genes). Four screening methods were applied to assess HSM, and postoperative outcomes were explored. In-depth blood and myocardial leukocyte phenotyping was performed in selected patients using mass cytometry and preoperative and postoperative RNA sequencing analysis of classical monocytes. RESULTS: The prevalence of HSM in the patient cohort ranged from 29%, when considering the conventional HSM panel (97 genes) with variant allelic frequencies ≥2%, to 60% when considering the full HemePACT panel and variant allelic frequencies ≥1%. Three of 4 explored HSM definitions were significantly associated with higher risk for POAF. On the basis of the most inclusive definition, HSM carriers exhibited a 3.5-fold higher risk for POAF (age-adjusted OR: 3.5; 95% CI: 1.52-8.03; P = 0.003) and an exaggerated inflammatory response following AVR. HSM carriers presented higher levels of activated CD64+CD14+CD16- circulating monocytes and inflammatory monocyte-derived macrophages in presurgery myocardium. CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).
引用
- Ninni S, Dombrowicz D, Kuznetsova T, et al. Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation. J Am Coll Cardiol. 2023. PMID: 36990546. doi:10.1016/j.jacc.2023.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。